Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis.
about
Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophiliaMicrobial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepaciaCharacterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. novAcinetobacter septicus sp. nov. association with a nosocomial outbreak of bacteremia in a neonatal intensive care unit.Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in comparison to 16S rRNA gene sequencing for species identification of nonfermenting bacteria.Preliminary evaluation of the API 20NE and RapID NF plus systems for rapid identification of Burkholderia pseudomallei and B. mallei.Outbreak of Corynebacterium pseudodiphtheriticum infection in cystic fibrosis patients, France.Identification of potential diagnostic markers among Burkholderia cenocepacia and B. multivorans supernatants.PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patientsThe changing microbial epidemiology in cystic fibrosis.Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, and IV by PCRIdentification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methodsDifferentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolatesDevelopment of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients.Capillary electrophoresis-single-strand conformation polymorphism analysis for rapid identification of Pseudomonas aeruginosa and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosisIdentification and detection of Stenotrophomonas maltophilia by rRNA-directed PCRTaxonomy and identification of the Burkholderia cepacia complexPCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients.Compliance of clinical microbiology laboratories in the United States with current recommendations for processing respiratory tract specimens from patients with cystic fibrosisOptimization of routine identification of clinically relevant Gram-negative bacteria by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry and the Bruker Biotyper.Low rates of Pseudomonas aeruginosa misidentification in isolates from cystic fibrosis patients.Manual and automated instrumentation for identification of Enterobacteriaceae and other aerobic gram-negative bacilli.Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis.Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture.Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex.Identification of Pandoraea species by 16S ribosomal DNA-based PCR assays.Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis.Species-specific PCR as a tool for the identification of Burkholderia gladioli.Biochemical and susceptibility tests useful for identification of nonfermenting gram-negative rods.Comparative evaluation of the BD Phoenix and VITEK 2 automated instruments for identification of isolates of the Burkholderia cepacia complex.Evaluation of MicroScan Autoscan for identification of Pseudomonas aeruginosa isolates from cystic fibrosis patients.Direct comparison of the BD phoenix system with the MicroScan WalkAway system for identification and antimicrobial susceptibility testing of Enterobacteriaceae and nonfermentative gram-negative organisms.Use of real-time PCR with multiple targets to identify Pseudomonas aeruginosa and other nonfermenting gram-negative bacilli from patients with cystic fibrosis.Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium.Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centersSuperiority of molecular techniques for identification of gram-negative, oxidase-positive rods, including morphologically nontypical Pseudomonas aeruginosa, from patients with cystic fibrosis.First isolation of two colistin-resistant emerging pathogens, Brevundimonas diminuta and Ochrobactrum anthropi, in a woman with cystic fibrosis: a case report.16S rRNA gene sequencing versus the API 20 NE system and the VITEK 2 ID-GNB card for identification of nonfermenting Gram-negative bacteria in the clinical laboratory.Burkholderia glumae infection in an infant with chronic granulomatous disease.Ochrobactrum anthropi misidentified as Shewanella putrefaciens.
P2860
Q24533461-899FEC95-AFBE-40A5-ABA1-0C840861137DQ29615286-A10F0B30-831B-49B4-A414-ABD5412BAAF2Q30695296-0C365904-8188-4369-9964-B0435D51B894Q31141383-281E894B-4D35-4B74-8975-A6C26BE2D837Q33327477-57F9B99A-D030-45CA-9F4B-55027BEF8F8BQ33592570-CC186D66-D1F8-440B-AA0D-B7386BC8EF93Q33647480-47F09541-9F67-4198-8364-E6E09494234FQ33681762-57CD0121-27AF-4264-BE2D-F97244FB9DB9Q33715997-2A1ABC29-6398-4FF9-899D-7164B7AAF122Q33825634-24963A56-3598-41A6-A85E-489BCE761C4AQ33960094-155729E1-3FD4-4D9C-8038-EF40849297BAQ33961376-0273F293-D36C-45DD-9624-068AE6302920Q33961420-ED832B96-641B-49DE-BA0A-E6BEC2637102Q33962895-81F22112-CBAC-47BE-AAF6-3AE95EDD359CQ33963123-5BC2BC75-143E-4158-A6F0-700759C513CAQ33970448-42D0B613-A2A7-4DD8-A4A1-D595FA105ECFQ33973532-0F5254A2-459A-49B7-85E4-BCC7B8B7C736Q33974179-3EA54FD7-22A3-4918-BDD0-E89E377466ADQ34568983-231A1755-7502-4552-B245-DF0961EB2EDEQ34593752-EBE6EADE-1A3A-4E0F-815C-D1DE2D2A2120Q34956792-70190E00-B72F-48AC-85B3-925FA6385B51Q36011374-6E8711B3-B72E-4A2E-9C95-5883545FDB5BQ36771148-F65E9770-D5FC-4E05-8E94-9D8DAD0877BDQ39460330-CD9F1467-3915-43D9-805E-5760658968F0Q39463759-95CEEF63-6683-4F0E-ABB6-2F8020D7F803Q39467342-DCD361B7-C755-4870-AE56-DF6C0A2AF2ABQ39467759-084AB885-8DDE-4DC6-88C5-448B0BD2D4FDQ39468059-CBBD71E0-3AD3-483D-A85C-64ED3275EFD1Q39626645-3BFC3FB7-19F7-42C9-8484-F7F5B573BE9DQ39665321-D31C6EEF-0F1F-422E-AE91-ACE9D87B2826Q39732748-1CC833EC-DC49-46A0-B8CE-5B6BE901CABAQ39762100-5E2B3621-8DA4-400B-8456-46A8728B4C74Q39887228-4267E4C5-C12F-47E2-8163-73A714ADDD9BQ40013162-186033F2-FF62-4E72-A795-A5CC7693A88CQ40014199-197E99D3-7AFC-430E-BDCD-A055EA877BD2Q41819863-40D89310-DD83-457F-8DD6-BE8F50B4A1ADQ41896105-450080D8-DEA3-450B-8604-4F80E7AD735AQ42912426-AB0B0A9E-3F19-4A8E-9565-460A91068E3FQ42912568-07DBD1E9-14E9-48BE-999D-BDC84DEC98ABQ42940470-02776B1D-213B-4DC6-BAD6-9F3EC69A6400
P2860
Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Accuracy of four commercial sy ...... patients with cystic fibrosis.
@en
type
label
Accuracy of four commercial sy ...... patients with cystic fibrosis.
@en
prefLabel
Accuracy of four commercial sy ...... patients with cystic fibrosis.
@en
P2093
P2860
P1476
Accuracy of four commercial sy ...... patients with cystic fibrosis
@en
P2093
Caracciolo JA
Eskridge B
Gilligan PH
P2860
P304
P407
P577
1996-04-01T00:00:00Z